{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:26:08Z","timestamp":1794407168717,"version":"4.9.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"AstraZeneca K.K."}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1136\/ijgc-2019-000384","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T09:45:15Z","timestamp":1561974315000},"page":"1043-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)"],"prefix":"10.1016","volume":"29","author":[{"given":"Takayuki","family":"Enomoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Jinushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Kigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-000384_bb0010","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z","article-title":"Hereditary and familial ovarian cancer in southern Ontario","volume":"74","author":"Narod","year":"1994","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-000384_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.critrevonc.2008.06.003","article-title":"Hereditary ovarian cancer","volume":"69","author":"Russo","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/ijgc-2019-000384_bb0020","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.1251827","article-title":"Two decades after BRCA: setting paradigms in personalized cancer care and prevention","volume":"343","author":"Couch","year":"2014","journal-title":"Science"},{"key":"10.1136\/ijgc-2019-000384_bb0025","doi-asserted-by":"crossref","first-page":"112258","DOI":"10.18632\/oncotarget.22733","article-title":"Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer","volume":"8","author":"Hirasawa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2019-000384_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1136\/ijgc-2019-000384_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10147-017-1182-2","article-title":"BRCA1 gene: function and deficiency","volume":"23","author":"Takaoka","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000384_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fonc.2018.00016","article-title":"Role of BRCA mutations in the modulation of response to platinum therapy","volume":"8","author":"Mylavarapu","year":"2018","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2019-000384_bb0045","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000384_bb0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41416-018-0217-4","article-title":"BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer","volume":"119","author":"Tsibulak","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2019-000384_bb0055","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/annonc\/mdq628","article-title":"Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients","volume":"22","author":"Vencken","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2019-000384_bb0060","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cncr.21276","article-title":"Prognostic impact of BRCA1 pathogenic and BRCA1\/BRCA2 unclassified variant mutations in patients with ovarian carcinoma","volume":"104","author":"Majdak","year":"2005","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2019-000384_bb0065","author":"NCCN Guidelines for Detection, Prevention & Risk Reduction","year":"2019","journal-title":"Genetic\/familial high-risk assessment: breast and ovarian version 2"},{"key":"10.1136\/ijgc-2019-000384_bb0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/AOG.0000000000002285","article-title":"Committee on Practice Bulletins-Gynecology, Committee on Genetics, Society of Gynecologic Oncology. Practice bulletin No. 182 summary: hereditary breast and ovarian cancer syndrome","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2019-000384_bb0075","first-page":"3144","article-title":"Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population","volume":"7","author":"Sekine","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2019-000384_bb0080","author":"Kurman","year":"2014"},{"key":"10.1136\/ijgc-2019-000384_bb0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1200\/JCO.2017.76.2781","article-title":"Evaluation of a streamlined oncologist-led BRCA mutation testing and counseling model for patients with ovarian cancer","volume":"36","author":"Colombo","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-000384_bb0090","doi-asserted-by":"crossref","first-page":"85529","DOI":"10.18632\/oncotarget.13456","article-title":"Prevalence and clinical significance of BRCA1\/2 germline and somatic mutations in Taiwanese patients with ovarian cancer","volume":"7","author":"Chao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2019-000384_bb0095","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e32","article-title":"Clinical statistics of gynecologic cancers in Japan","volume":"28","author":"Yamagami","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-000384_bb0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2019-000384_bb0105","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2019-000384_bb0110","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41431-018-0111-9","article-title":"The association between cancer family history and ovarian cancer risk in BRCA1\/2 mutation carriers: can it be explained by the mutation position?","volume":"26","author":"Teixeira","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1136\/ijgc-2019-000384_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/1055-9965.EPI-05-0687","article-title":"Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations","volume":"15","author":"Lee","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2019-000384_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2019-000384_bb0125","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2019-000384_bb0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ygyno.2017.01.030","article-title":"Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics","volume":"145","author":"Kentwell","year":"2017","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24002329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-000384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:37:41Z","timestamp":1753101461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24002329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1048891X24002329"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-000384","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2019-000384.supp2","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2019-000384.supp1","asserted-by":"subject"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-000384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 This is an Open Access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https:\/\/creativecommons.org\/licenses\/by\/4.0\/.","name":"copyright","label":"Copyright"}]}}